Loading clinical trials...
Loading clinical trials...
Efficacy of Rivastigmine in the Management of Toxic Anticholinergic Delirium: A Prospective Study at Alexandria Poison Center
Conditions
Interventions
Rivastigmine
Locations
1
Egypt
Poison Control Center (PCC), Alexandria University Main Hospital
Alexandria, Egypt
Start Date
December 8, 2025
Primary Completion Date
April 15, 2026
Completion Date
April 15, 2026
Last Updated
April 22, 2026
Lead Sponsor
Alexandria University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions